A Johns Hopkins University meta-analysis released in January found that lockdowns across Europe and the U.S. reduced the COVID-19 mortality by 0.2%.
The researchers’ analysis of “lockdown measures” included school closures, business closures, bans on international travel and internal movement, and other non-pharmaceutical government mandates such as mask mandates.
Hopkins: “evidence fails to confirm that lockdowns have a significant effect in reducing COVID-19 mortality. The effect is little to none … However, lockdowns during the initial phase of the pandemic had devastating effects” https://t.co/N2PbeUr3yY Apologies not sufficient. pic.twitter.com/CJ8B0MLjsB
— Scott W. Atlas (@ScottWAtlas) January 31, 2022
The study also found that shelter in place orders were ineffective, reducing mortality by only 2.9%. (RELATED: West Australia Threatens $50,000 Fine And Jail Time For People Who Are ‘Offensive’ To Workers Checking Vax Cards)
“While this meta-analysis concludes that lockdowns have had little to no public health effects, they have imposed enormous economic and social cost,” the study concluded. “In consequence, lockdown policies are ill-founded and should be rejected as a pandemic policy instrument.”
”Lockdowns have limited peoples’ access to safe (outdoor) places such as beaches, parks, and zoos, or included outdoor mask mandates or strict outdoor gathering restrictions, pushing people to meet at less safe (indoor) places,” the researchers noted. “We do find some evidence that limiting gatherings was counterproductive and increased COVID-19 mortality.”
Johns Hopkins University itself made classes fully remote in the fall 2020 semester and urged students not to travel to Baltimore before moving to a partially in-person model in the spring 2021 semester. The school still imposes a mask mandate, requiring two masks or a surgical grade mask, despite nearly universal vaccination of students and staff, a booster shot and a twice-weekly testing requirement.
Content created by The Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact email@example.com.